Registration number: 09107848

TRIGENEX LTD

Contents

Company Information	1
Abridged Balance Sheet	2 to 3
Notes to the Unaudited Abridged Financial Statements	4 to 9

TRIGENEX LTD

Company Information

Directors

Mr Adam Triantis Deepbridge NED Limited Mr Mitesh Jatania Ms Ruth Renee de Leo

Registered office

C/o Nexus Solicitors Carlton House 16-18 Albert Square Manchester M2 5PE

Accountants

GRC Accountants Limited 166 Banks Road West Kirby Wirral Merseyside CH48 0RH

TRIGENEX LTD

(Registration number: 09107848)
Abridged Balance Sheet as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	4	9,278	-
Tangible assets	5	53,057	45,096
		62,335	45,096
Current assets
Stocks	6	244,282	87,769
Debtors	7	54,368	49,254
Cash at bank and in hand		98,271	42,158
		396,921	179,181
Prepayments and accrued income		65,454	19,084
Creditors: Amounts falling due within one year		(467,686)	(357,710)
Net current liabilities		(5,311)	(159,445)
Total assets less current liabilities		57,024	(114,349)
Creditors: Amounts falling due after more than one year		(8,312)	(17,550)
Accruals and deferred income		(55,487)	(52,982)
Net liabilities		(6,775)	(184,881)
Capital and reserves
Called up share capital	8	286	206
Share premium reserve		4,524,708	3,081,727
Retained earnings		(4,531,769)	(3,266,814)
Shareholders' deficit		(6,775)	(184,881)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

TRIGENEX LTD

(Registration number: 09107848)
Abridged Balance Sheet as at 31 March 2025

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 29 December 2025 and signed on its behalf by:
 

.........................................

Ms Ruth Renee de Leo

Director

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
C/o Nexus Solicitors Carlton House
16-18 Albert Square
Manchester
M2 5PE
England

The company exceeded the micro-entity thresholds and therefore is required to prepare its accounts under FRS 102 Section 1A for the first time. The transition from FRS 105 to FRS 102 has not resulted in any material changes to the amounts recognised in these financial statements.

These financial statements were authorised for issue by the Board on 29 December 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant & Machinery	25% straight line
Computer equipment	33.3% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2024 - 9).

4	Intangible assets

	Total £
Cost or valuation
Additions acquired separately	9,278
At 31 March 2025	9,278
Amortisation
Carrying amount
At 31 March 2025	9,278

The aggregate amount of research and development expenditure recognised as an expense during the period is £37,812 (2024 - £39,430).
 

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

5	Tangible assets

	Furniture, fittings and equipment  £	Other tangible assets £	Total £
Cost or valuation
At 1 April 2024	5,627	75,854	81,481
Additions	961	28,624	29,585
At 31 March 2025	6,588	104,478	111,066
Depreciation
At 1 April 2024	5,163	31,222	36,385
Charge for the year	572	21,052	21,624
At 31 March 2025	5,735	52,274	58,009
Carrying amount
At 31 March 2025	853	52,204	53,057
At 31 March 2024	464	44,632	45,096

6

Stocks

	2025 £	2024 £
Other inventories	244,282	87,769

7

Debtors

Debtors includes £Nil (2024 - £Nil) due after more than one year.

8	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
Preference of £0.00 each	-	-	53,148	53
Ordinary of £0.00 each	285,563	286	152,669	153
	285,563	286	205,817	206

9	Related party transactions

TRIGENEX LTD

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Summary of transactions with entities with joint control or significant interest

 
AURÉA Fund 1 GP Limited

Relationship: Person with Significant Control

Nature: Corporate PSC Amount: £3,000 (2024: £40,855)

Deepbridge Capital LLP

Relationship: Director of the company

Nature: Corporate director providing services

Amount: £46,036 (2024: £26,125)